Article
The Effects of CYP2C19 genotype on the susceptibility for nephrosis in cardio-cerebral vascular disease treated by anticoagulation.
Medicine - 1 Sept 2016
Chang Kai, Jiang Zhongyong, Liu Chenxia, Ren Junlong, Wang Ting, Xiong Jie
Abstract excerpt
In recent years, the genetic factor has become one of the important predisposing factors of nephropathy susceptibility. There is a high incidence of nephropathy in CCVd. The CYP2C19 enzyme metabolizes most the drugs, including proton pump inhibitors commonly used medicines to treat CCVd, CYP2C19 genetic polymorphisms is association with multi-pathogenesis factors of nephropathy. The purpose of the study is to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
